These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 571917)

  • 21. Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat.
    Miller JC; Friedhoff AJ
    Dev Neurosci; 1986; 8(2):111-6. PubMed ID: 2427306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereospecific blockade of alpha 2-adrenoceptors by (+)-butaclamol: implications for the characterization of dopamine receptors.
    Spedding M; Berg C
    J Pharm Pharmacol; 1982 Jan; 34(1):56-8. PubMed ID: 6174723
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.
    Yevich JP; New JS; Smith DW; Lobeck WG; Catt JD; Minielli JL; Eison MS; Taylor DP; Riblet LA; Temple DL
    J Med Chem; 1986 Mar; 29(3):359-69. PubMed ID: 2869146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
    Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J
    Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (+)-Isobutaclamol: a crystallographic, pharmacological, and biochemical study.
    Humber LG; Philipp AH; Voith K; Pugsley T; Lippmann W; Ahmed FR; Przybylska M
    J Med Chem; 1979 Aug; 22(8):899-901. PubMed ID: 490535
    [No Abstract]   [Full Text] [Related]  

  • 27. The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.
    Tedesco JL; Seeman P; McDermed JD
    Mol Pharmacol; 1979 Sep; 16(2):369-81. PubMed ID: 514252
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 29. Histamine-, norepinephrine-, and dopamine-sensitive central adenylate cyclases: effects of chlorpromazine derivatives and butaclamol.
    Palmer GC; Wagner HR; Palmer SJ; Manian AA
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):314-25. PubMed ID: 687395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines.
    Harbert CA; Plattner JJ; Welch WM; Weissman A; Koe BK
    J Med Chem; 1980 Jun; 23(6):635-43. PubMed ID: 6104732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity.
    New JS; Christopher WL; Yevich JP; Butler R; Schlemmer RF; VanderMaelen CP; Cipollina JA
    J Med Chem; 1989 Jun; 32(6):1147-56. PubMed ID: 2542551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
    Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping brain neuroleptic receptors in the live baboon.
    Arnett CD; Fowler JS; Wolf AP; Logan J; MacGregor RR
    Biol Psychiatry; 1984 Oct; 19(10):1365-75. PubMed ID: 6083807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine antagonists reduce spontaneous electrical activity in cultured mammalian neurons from ventral mesencephalon.
    Heyer EJ
    Brain Res; 1986 Sep; 382(2):404-8. PubMed ID: 2428448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 39. 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: a new heterocyclic system and a new lead compound for dopamine receptor antagonists.
    Witt T; Hock FJ; Lehmann J
    J Med Chem; 2000 May; 43(10):2079-81. PubMed ID: 10821720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of R(+)-ADTN in dopamine receptor binding assays.
    Davis A; Poat JA; Woodruff GN
    Eur J Pharmacol; 1980 May; 63(2-3):237-8. PubMed ID: 6155278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.